Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

26.45 -0.34 (-1.25%)
Streaming Delayed Price Updated: 10:16 AM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,814
Open 26.60
Bid (Size) 26.28 (4)
Ask (Size) 26.60 (3)
Prev. Close 26.78
Today's Range 26.22 - 27.09
52wk Range 23.23 - 42.29
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
2 Reasons to Watch COLL and 1 to Stay Cautious
Collegium Pharmaceutical’s stock price has taken a beating over the past six months, shedding 31.6% of its value and falling to $26.01 per share. This might have investors contemplating their next... 
Via StockStory

Performance

YTD
-7.6%
-7.6%
1 Month
-12.3%
-12.3%
3 Month
-16.9%
-16.9%
6 Month
-22.9%
-22.9%
1 Year
-25.5%
-25.5%

More News

Read More
What Analysts Are Saying About Collegium Pharmaceutical Stock
Via Benzinga
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Earnings Scheduled For February 27, 2025
Via Benzinga
A Preview Of Collegium Pharmaceutical's Earnings
Via Benzinga
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
From Avalo Therapeutics
Via GlobeNewswire
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical
Via Benzinga
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Collegium Announces Updates to its Board of Directors and Executive Leadership Team
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%
Via StockStory
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect
Via StockStory
Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Appoints Nancy S. Lurker to its Board of Directors
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium's Revenue Outlook And CNS Expansion Signal Undervalued Opportunity, Says Needham
Via Benzinga
Collegium Provides 2025 Financial Guidance and Business Update
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Reports Record Third Quarter 2024 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium Appoints Vikram Karnani as Chief Executive Officer
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 26.45
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 04/25/25 10:16 AM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 852.86M
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 853M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.